Introduction:

Endoscopic Retrograde Cholangiopancreatography (ERCP) is currently the standard technique for the treatment of choledocholithiasis and associated complications such as cholangitis, biliary stenosis, etc. in the general population. The management of pregnant women with suspected choledocholithiasis differs slightly from that of the general population due to concerns about the pregnant mother and the fetus, including the time of the procedure, duration of fluoroscopic management, medications and exposure to fetal radiation as well as the associated complications.

Objective:

Systematic review of safety in endoscopic cholangiopancreatography in pregnant women in the Hospital Juárez de México.

Material and methods:

Retrospective, observational, transversal and descriptive study. By means of a bibliographic review, the data referring to complications after endoscopic cholangiopancreatography were compiled in Excel sheet (Office Professional 2016) from March 2009 to March 2019 at the Hospital Juárez de México.

Results:

32 endoscopic cholangiopancreatographies were performed on pregnant women during March 2009 to March 2019, however, 12 patients were excluded because they did not have the necessary information for the study. A sample of 20 patients was obtained, of which 2 patients (10%) developed post-CPE pancreatitis. No development of bleeding, perforation or cholangitis after the procedure. Regarding obstetric complications, 6 patients (30%) had a preterm birth, of which 5 patients (25%) were performed and 4 newborns (20%) were underweight, which is to be expected from the percentage of preterm labor.

Conclusions:

CPE is the method of choice for choledocholithiasis. Pregnant women have predisposing factors for the development of choledocholithiasis. A percentage of 10% of post-CPE pancreatitis was observed, which is greater than the general population.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )